25Sep
20Sep
Respiratory Motion, Inc. Awarded National Group Breakthrough Technologies Purchasing Contract by Premier
Respiratory Motion, Inc. is announcing the award of a group purchasing agreement as a Breakthrough Technology with Premier Inc., a leading healthcare improvement company. Read more >>
19Sep
Myomo to Present at The MicroCap Conference
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track 1, Essex House in New York City. Read more >>
19Sep
Corbus Pharmaceuticals receives Orphan Designation for lenabasum for the treatment of DM in EU
Corbus Pharmaceuticals announces that the European Commission has granted Orphan Designation in the European Union (EU) to lenabasum, its synthetic oral endocannabinoid-mimetic drug, for the treatment of dermatomyositis (DM). Read more >>
15Sep
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today that its abstracts have been selected for presentations at the American College of Rheumatology (“ACR”) 2018 Annual Meeting being held October 19-24, 2018 in Chicago, Illinois. Read more >>
14Sep
Visual ability, reading improves with eSight low vision device
Study participants who wore the head-mounted low vision device, eSight, experienced immediate improvements in visual ability, facial recognition and activities of daily living, according to researchers. Read more >>
14Sep
KnipBio completes trial on feed efficacy product
US firm KnipBio has successfully completed a feed efficacy trial on Atlantic salmon, marking the third version of its single-cell protein to pass quality and efficacy trials. Read more >>
13Sep
KnipBio heralds astaxanthin-rich protein feed test outcome
Next stage in fish nutrition project moves to large scale field trials. Read More >>
13Sep
Wasabi Secures $68 Million Funding Round, Bypasses Traditional VC Financing
Wasabi, the hot cloud storage company, today announces the closing of a Series B financing round totaling $68 million. Wasabi refrained from conventional venture capital, preferring instead to raise money from industry veterans and family offices. The investment is a testament to Wasabi’s progress in becoming a leading vendor of cheap, fast, and secure cloud storage. In just over a year, Wasabi has acquired more than 3,000 customers across a wide range of industries. Read more >>
07Sep